Akums Drugs and Pharmaceuticals Limited
Source: NSE · Updated 4 Nov, 11:32 pm IST
Numbers from the company's structured XBRL filing on NSE, cross-checked with P&L totals.
Quarter comparison
| Item | Q2 FY27 (Sep ’26) | Q1 FY27 (Jun ’26) | vs Q1 FY27 | Q2 FY26 (Sep ’25) | vs Q2 FY26 |
|---|---|---|---|---|---|
| Revenue from operations | 13,423.87 | — | — | — | — |
| Other income | 289.06 | 303.8 | ▼ 4.9% | 323.65 | ▼ 10.7% |
| Operating profit (EBITDA)* | 1,947.28 | — | — | — | — |
| Net profit | 1,145.65 | — | — | — | — |
| EPS (₹) | 7.37 | — | — | — | — |
| Operating margin | 14.5% | — | — | — | — |
| Net margin | 8.5% | — | — | — | — |
Showing Q2 FY27 (Sep ’26) and change vs Q2 FY26. Turn your phone sideways for Q1 FY27 (Jun ’26).
Figures in ₹ millions except EPS. Consolidated figures from the company's XBRL filing on NSE. Each row is shown only if it reconciles with the others (e.g. PBT − tax = net profit); rows we couldn't verify are left out. Net margin = net profit ÷ revenue. *Operating profit (EBITDA), derived from the filing: profit before exceptional items and tax + finance costs + depreciation − other income. Operating margin = EBITDA ÷ revenue.
All Akums Drugs and Pharmaceuticals results, dividends & filings ›Other results filed 2 Nov
FAQ
When did Akums Drugs and Pharmaceuticals announce Q2 FY27 results?
Akums Drugs and Pharmaceuticals filed its results on NSE on 2 Nov, 05:14 pm IST.
What does QoQ and YoY mean?
QoQ compares with the previous quarter; YoY compares with the same quarter last year. Growth is calculated from the figures in the filing.
Are these Akums Drugs and Pharmaceuticals figures official?
They are auto-read from the company's NSE filing and may contain errors. Always confirm with the official PDF linked on this page.
Explore
Figures are auto-read from the company's NSE filing and may contain errors. Check the official filing before deciding. Not investment advice.
← AKUMS overviewNothing matches.